Dr. Ido Wolf is a leading oncologist, cancer researcher, and Head of Oncology at Tel Aviv Sourasky Medical Center. In 2022, he was appointed Head of the Tel Aviv University Medical School. Renowned for his work in gastrointestinal and neuroendocrine tumors, Dr. Wolf has pioneered personalized therapies and protocols that significantly improve pancreatic cancer outcomes. He has authored over 120 publications on topics from cancer genomics to immunotherapy and AI in oncology. A former research fellow at UCLA, he serves as Chair of Israel’s National Council for Cancer and is a member of ASCO, AACR, and ISCORT.